|
⚲
|
| Keyboard |
| Arsanis Inc | |
|---|---|
| Ticker | XFOR |
| CIK # | 0001501697 |
| CUSIP | 98420X103 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 890 Winter Street, Suite 230, Waltham, MA 02451 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| X4 Pharmaceuticals Inc | 2025-08-25 | 85.0 M | Exemption: 506(b) · Duration: One year or less · Commission: $3,300,000 · Revenue: Decline to Disclose |
| Arsanis Inc | 2017-12-04 | 20.0 M | Exemption: 506(c) · Duration: One year or less · Commission: $1,400,000 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001501697] | 10-K | |
| [0001501697] | 10-Q | |
| [0001501697] | 3 | |
| [0001501697] | 4 | |
| [0001501697] | 8-K | |
| [0001501697] | D | |
| [0001501697] | SC 13D | |
| [0001501697] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
de Craecker Francoise
Stock Option (right to buy) · derivative
|
2026-01-01 | Grant | 110,000 | $0.00 | |
|
Bridger Gary
Stock Option (right to buy) · derivative
|
2026-01-01 | Grant | 110,000 | $0.00 | |
|
Stewart Murray
Stock Option (right to buy) · derivative
|
2026-01-01 | Grant | 110,000 | $0.00 | |
|
Wyzga Michael S
Stock Option (right to buy) · derivative
|
2026-01-01 | Grant | 110,000 | $0.00 | |
|
Volpone John
Stock Option (right to buy) · derivative
|
2025-10-29 | Grant | 2,329,154 | $0.00 | |
|
Kirske David
Stock Option (right to buy) · derivative
|
2025-10-29 | Grant | 1,552,769 | $0.00 | |
|
Craig Adam R
Stock Option (right to buy) · derivative
|
2025-10-29 | Grant | 2,329,154 | $0.00 | |
|
Craig Adam R
Common Stock
|
2025-10-23 | Buy | 86,206 | $2.90 | 249,997 |
|
Kirske David
Stock Option (right to buy) · derivative
|
2025-08-14 | Grant | 352,800 | $0.00 | |
|
Craig Adam R
Common Stock
|
2025-08-14 | Grant | 289,881 | $0.00 | |
|
Volpone John
Common Stock
|
2025-08-14 | Grant | 289,881 | $0.00 | |
|
Craig Adam R
Stock Option (right to buy) · derivative
|
2025-08-14 | Grant | 529,201 | $0.00 | |
|
Volpone John
Stock Option (right to buy) · derivative
|
2025-08-14 | Grant | 529,201 | $0.00 | |
|
Kirske David
Common Stock
|
2025-08-14 | Grant | 193,254 | $0.00 | |
|
Craig Adam R
Stock Option (right to buy) · derivative
|
2025-08-12 | Grant | 1,609,873 | $0.00 | |
|
Volpone John
Stock Option (right to buy) · derivative
|
2025-08-12 | Grant | 1,609,873 | $0.00 | |
|
Kirske David
Stock Option (right to buy) · derivative
|
2025-08-12 | Grant | 1,073,249 | $0.00 | |
|
Wyzga Michael S
Common Stock
|
2025-06-09 | Grant | 1,500 | $0.00 | |
|
Woods Keith
Common Stock
|
2025-06-09 | Grant | 1,500 | $0.00 | |
|
Bridger Gary
Common Stock
|
2025-06-09 | Grant | 1,500 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 84 | 98,479,119 |
| 2025-12-31 | 79 | 89,554,970 |
| 2025-09-30 | 43 | 16,287,304 |
| 2025-06-30 | 53 | 2,935,220 |
| 2025-03-31 | 97 | 99,183,104 |
| 2024-12-31 | 92 | 100,351,339 |
| 2024-09-30 | 100 | 100,930,124 |
| 2024-06-30 | 102 | 105,178,886 |
| 2024-03-31 | 100 | 106,180,108 |
| 2023-12-31 | 95 | 104,045,346 |
| 2023-09-30 | 92 | 112,687,167 |
| 2023-06-30 | 100 | 118,478,715 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Pettinga Financial Advisors LLC | [2026-06-30] | SOLE | 0 | 10,000 | Prev | Page 1 | Next |